期刊文献+

RNA干扰靶向抑制PI3K p85α蛋白对大肠癌细胞侵袭与转移的影响 被引量:1

Influence of RNA interference targeting PI3K p85α expression on invasion and metastasis of colorectal cancer cells
下载PDF
导出
摘要 目的:探讨RNA干扰靶向抑制PI3Kp85α蛋白表达对大肠癌细胞侵袭与转移的影响。方法:设计4条shRNA干扰载体及1条阴性对照载体,分别稳定转染大肠癌LoVo细胞。用蛋白质印迹法筛选出一组抑制效率最高的细胞进行细胞划痕实验和Transwell实验。结果:转染shRNA/324干扰载体的LoVo细胞PI3Kp85α蛋白表达降低最明显,抑制率达77%,选择该组细胞作为有效干扰组进行后续实验。细胞划痕实验显示,干扰组细胞的划痕愈合能力明显低于对照组细胞(P<0.05)。Transwell实验显示,干扰组细胞的穿膜细胞数明显少于对照组细胞(P<0.05)。结论:PI3Kp85α蛋白表达缺失可明显降低大肠癌LoVo细胞的迁移运动能力,PI3Kp85α可能成为治疗大肠癌转移的新靶点。 Objective:To investigate the influence of RNA interference targeting PI3K p85α on the invasion and metastasis of coloreetal cancer cells. Methods: Four shRNA vectors and one negative control vector were designed and stably transfected into LoVo cells. Western blotting analysis was used to screen for the group which had the highest inhibitory rate; the cells were subjected to wound closure assay and transwell assay to determine the migration of LoVo cells after stable transfection. Results: Western blotting analysis showed that ceils transfected with shRNA/324 vector had the strongest inhibition of PI3K p85α protein,with the inhibition rate being 77%, and cells in this group were used for wound closure assay and transwell assay. Wound closure assay showed that the healing ability of PI3K p85α-depleted cells was significantly lower than that of the control cells (P〈0. 05). Transwell assay showed that the cells passing the polycarbonate membranes was significantly less in PI3K p85α-knoekdown cells than in the control cells (P〈0.05). Conclusion:Depletion of PI3K p85a protein can obviously inhibit the migration of LoVo cells. PIaK p85α may be a new therapeutic target /or treatment of eolorectal cancer metastasis.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2009年第5期496-499,共4页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(30300159)~~
关键词 结直肠肿瘤 磷脂酰肌醇3-激酶p85α亚单位 RNA干扰 肿瘤转移 coloreetal neoplasms PI3K p85α RNA interference neoplasm metastasis
  • 相关文献

参考文献13

  • 1Cercek A,Saltz L B.First-line treatment of patients with metastatic colorectal cancer:an overview of recent data on chemotherapy plus targeted agents[J].Clin Colorectal Cancer,2008,7(Suppl 2):S47-S51.
  • 2Osaki M,Oshimura M,Ito H.PI3K-Akt pathway:its functions and alterations in human cancer[J].Apoptosis,2004,9:667-676.
  • 3Philp A J,Campbell I G,Leet C,Vincan E,Rockman S P,Whitehead R H,et al.The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors[J].Cancer Res,2001,61:7426-7429.
  • 4Tuschl T.Expanding small RNA interference[J].Nat Biotechnol,2002,20:446-448.
  • 5Hu M,Polyak K.Molecular characterisation of the tumour microenvironment in breast cancer[J].Eur J Cancer,2008,44:2760-2765.
  • 6Bellacosa A,de Feo D,Godwin A K,Bell D W,Cheng J Q,Altomare D A,et al.Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas[J].Int J Cancer,1995,64:280-285.
  • 7Cheng J Q,Ruggeri B,Klein W M,Sonoda G,Altomare D A,Watson D K,et al.Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA[J].Proc Natl Acad Sci USA,1996,93:3636-3641.
  • 8Ringel M D,Hayre N,Saito J,Saunier B,Schuppert F,Burch H,et al.Overexpression and overactivation of Akt in thyroid carcinoma[J].Cancer Res,2001,61:6105-6111.
  • 9胡蕾,姜汉国.PI3K/AKT信号转导通路与肿瘤转移及其机制的研究进展[J].医学综述,2006,12(22):1375-1377. 被引量:18
  • 10孙嫣,田华,肖法嫚,谢晓云,宋于刚.PI3K p85α在大肠癌癌变过程中的表达及意义[J].南方医科大学学报,2009,29(3):416-418. 被引量:14

二级参考文献31

  • 1Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: Its functions and alterations in human cancer [J].Apoptosis, 2004, 9 (6): 667-76.
  • 2Carter JH, Douglass LE, Deddens JA, et al. Pak-1 expression increases with progression of colorectal carcinomas to metastasis [J]. Clin Cancer Res, 2004, 10 (10): 3448-56.
  • 3Dong Z, Huang C, Ma WY. PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer [J]. Anticancer Res, 2001, 19 (5A): 3743-7.
  • 4Chang F, Lee JT, Navolanic PM, et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy[J]. Leukemia, 2003, 17 (3): 590-603.
  • 5Jimenez C, Jones DR, Rodriguez-Viciana P, et al. Identification and characterization of a new oneogene derived from the regulatory subunit ofphosphoinositide 3-kinase[J]. EMBO J, 1998, 17 (3): 743-53.
  • 6Philp AJ, Campbell IG, Leet C, et al. The phosphatidylinositol 3'-kinase p85 alpha gene is an oncogene in human ovarian and colon tumors[J]. Cancer Res, 2001, 61 (20): 7426-9.
  • 7Lee SH, Kim HS, Park WS, et al. Non-small cell lung cancers frequently express phosphorylated Akt; an immunohistuchemical study [J]. APMIS, 2002, 110 (7-8): 587-92.
  • 8Itoh N, Semba S, Ito M, et al, Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma[J]. Cancer, 2002, 94 (12): 3127-34.
  • 9Shukla S, Maclennan GT, Marengo SR, et al. Constitutive activation of PI3K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model[J]. Prostate, 2005, 64 (3): 224-39.
  • 10Saal LH, Holm K, Maurer M, et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutuaUy exclusive with PTEN loss in human breast carcinoma[J]. Cancer Res, 2005, 65 (7): 2554-9.

共引文献30

同被引文献12

  • 1Hong YS, Kim TW. Chemotherapy for colorectal cancer [ J]. Korean J Gastroenterol, 2009, 54 (6): 355-363.
  • 2Falasca M. PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs [ J]. Curr Pharm Des, 2010, 16 (12): 1410-1416.
  • 3Ahn S, Kim J, Hara MR, et al.{ beta} -Arrestin-2 mediates anti-apoptotic signaling through regulation of BAD phosphorylation [J]. J Biol Chem, 2009, 284 (13): 8855-8865.
  • 4del Peso L, Gonzalez-Garcia M, Page C, et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt [ J]. Science, 1997, 278 (5338) : 687-689.
  • 5Sarker D, Reid AH, Yap TA, et al. Targeting the PI3K/AKT pathway for the treatment of prostate cancer [ J]. Clin Cancer Res, 2009, 15 (15) : 4799-4805.
  • 6Nicholson KM, Anderson NG. The protein kinase B/Akt signaling pathway in human malignancy [J]. Cell Signal, 2002, 14 (5) : 381- 395.
  • 7Jiang JX, Mikami K, Venugopal S, et al. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways [ J]. J Hepatol, 2009, 51 ( 1 ) : 139-148.
  • 8Lauder A, Castellanos A, Weston K. c-Myb transcription is activated by protein kinase B ( PKB ) following interleukin 2 stimulationof T cell and is required for PKB-mediated protein from apoptosis [ J]. Mol Cell Biol, 2001, 21(49): 5797-5805.
  • 9Du K, Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB [J]. J Biol Chem, 1998, 273(49) : 32377-32379.
  • 10Rychahou PG, Murillo CA, Evers BM. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis inducing ligand (TRAIL) [ J]. Surgery, 2005, 138 (2) : 391-397.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部